ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,309Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 403

$1.66M Total Retail Price of All Prescriptions

Rank: 1 out of 403

657 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 657 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 657 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

3% of this provider’s 20,403 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 810 692 1 7
OMEPRAZOLE 752 588 2 9
LEVOTHYROXINE SODIUM 702 596 3 3
GABAPENTIN 598 456 4 17
HYDROCODONE-ACETAMINOPHEN 570 353 S3 5 15
METFORMIN HCL 565 432 6 8
LISINOPRIL 564 441 7 1
POTASSIUM CHLORIDE 539 486 8 37
SIMVASTATIN 526 453 9 2
TRAMADOL HCL 454 328 10 28
AMLODIPINE BESYLATE 445 381 11 4
METOPROLOL TARTRATE 398 327 12 10
DONEPEZIL HCL 371 365 13 23
PRAVASTATIN SODIUM 355 256 14 14
SPIRIVA 319 215 15 35
NAMENDA 292 268 16 41
POLYETHYLENE GLYCOL 3350 277 260 17 60
CARVEDILOL 269 210 18 32
TAMSULOSIN HCL 261 233 19 27
FLUTICASONE PROPIONATE 259 174 20 47
CLONIDINE HCL 254 183 21 127
KLOR-CON 8 250 172 22 156
TRAZODONE HCL 246 163 23 25
ROPINIROLE HCL 245 181 24 123
CYCLOBENZAPRINE HCL 235 152 R 25 91
HYDROCHLOROTHIAZIDE 230 203 26 6
CLOPIDOGREL 225 168 27 55
WARFARIN SODIUM 211 175 28 12
SPIRONOLACTONE 205 157 29 100
FLUOXETINE HCL 205 169 29 57
SERTRALINE HCL 201 156 31 20
ATENOLOL 199 160 32 13
ZOLPIDEM TARTRATE 196 144 33 16
CYMBALTA 192 132 34 43
CARBIDOPA-LEVODOPA 190 160 35 78
MELOXICAM 189 150 36 58
PREDNISONE 186 146 37 34
SUCRALFATE 176 166 38 177
LEVOFLOXACIN 173 126 39 99
ADVAIR DISKUS 173 133 39 33
CITALOPRAM HBR 171 108 41 22
ATORVASTATIN CALCIUM 171 122 41 5
RANITIDINE HCL 166 110 43 46
OXYCODONE HCL-ACETAMINOPHEN 164 131 S2 44 89
DIGOXIN 161 134 45 56
AZITHROMYCIN 161 115 45 49
PROAIR HFA 159 108 47 40
FENTANYL 157 142 S2 48 71
PAROXETINE HCL 156 123 49 68
LANTUS 155 105 50 54
ALENDRONATE SODIUM 152 140 51 26
JANUVIA 150 126 52 44
LOSARTAN POTASSIUM 143 116 53 21
ALLOPURINOL 137 119 54 31
ISOSORBIDE MONONITRATE ER 131 103 55 62
PLAVIX 129 100 56 83
CIPROFLOXACIN HCL 129 108 56 130
NEXIUM 125 72 58 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 123 102 59 29
DIOVAN 119 101 60 24
MEGESTROL ACETATE 110 98 R 61 201
CRESTOR 109 91 62 19
OXYCONTIN 108 56 S2 63 63
HYDRALAZINE HCL 108 64 63 115
MORPHINE SULFATE ER 103 59 S2 65 104
QUINAPRIL HCL 101 72 66 67
NAPROXEN 100 83 67 79
METOPROLOL SUCCINATE 100 65 67 11
AMOX TR-POTASSIUM CLAVULANATE 99 67 69 183
ENALAPRIL MALEATE 97 63 70 66
GLIPIZIDE 95 64 71 70
HUMULIN N 94 73 72 211
BUPROPION HCL SR 93 67 73 125
MIRTAZAPINE 93 60 73 38
LOSARTAN-HYDROCHLOROTHIAZIDE 91 83 75 91
OXYBUTYNIN CHLORIDE 87 85 76 156
IBUPROFEN 83 57 77 93
NITROFURANTOIN 82 69 78 183
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 59 78 106
INSULIN SYRINGE 81 58 80 145
CARISOPRODOL 81 23 R 80 190
LOVASTATIN 79 79 82 42
GLYBURIDE 78 51 R 83 88
VENTOLIN HFA 77 38 84 109
TRIAMTERENE-HCTZ 77 48 84 76
PANTOPRAZOLE SODIUM 77 62 84 30
LYRICA 75 75 87 116
BENAZEPRIL HCL 75 70 87 72
FINASTERIDE 75 65 87 82
TRICOR 75 74 87 90
PREMARIN 75 48 R 87 191
DETROL LA 74 63 92 174
FLUCONAZOLE 74 54 92 222
METOCLOPRAMIDE HCL 74 63 92 222
GLIMEPIRIDE 74 74 92 61
AMIODARONE HCL 73 60 96 224
PROMETHAZINE HCL 71 47 R 97 225
RISPERIDONE 70 42 98 48
ENDOCET 70 36 S2 98 189
VENLAFAXINE HCL ER 70 68 98 95
AMITRIPTYLINE HCL 69 36 R 101 131
TERAZOSIN HCL 68 36 102 198
ESTRADIOL 68 37 R 102 227
PROPRANOLOL HCL 66 46 104 138
SINGULAIR 66 42 104 65
GLIPIZIDE ER 66 43 104 86
PHENYTOIN SODIUM EXTENDED 65 31 107 166
LANTUS SOLOSTAR 65 34 107 80
QUETIAPINE FUMARATE 64 59 109 52
DILTIAZEM 24HR CD 62 47 110 102
TORSEMIDE 61 47 111 195
HYDROXYZINE PAMOATE 61 44 R 111 178
CLINDAMYCIN HCL 59 42 113 241
DILTIAZEM ER 58 54 114 243
BYSTOLIC 58 51 114 94
AVODART 58 55 114 176
OXYCODONE HCL 55 18 S2 117 39
LOPERAMIDE 55 51 117 248
MUPIROCIN 54 36 119 203
SYMBICORT 53 44 120 174
NOVOLOG 52 35 121 117
TRIAMCINOLONE ACETONIDE 52 37 121 149
VESICARE 52 52 121 200
CELEBREX 51 45 124 87
SYNTHROID 51 50 124 51
BYETTA 51 28 124 263
NITROSTAT 51 39 124 263
OXYCODONE-ACETAMINOPHEN 50 29 S2 128 45
EXELON 50 41 128 114
KLOR-CON M10 50 37 128 209
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.